The Monster Mash World Record event was a short one on May 24, 2025, in Grow a Garden. In an attempt to reach record player numbers, the Roblox servers struggled to keep up with the demand.

The Monster Mash event in Grow a Garden was a world record attempt for getting the most people doing the Monster Mash dance at the same time. While this short event has been and gone, you may have ...

I believe that the most promising aspect about it would be the fact that it is going after a MASH patient population that has not been sought out after very much. Specifically, this involves the ...

At 36 weeks, a reduction in fibrosis without worsening of MASH occurred in 8 of 61 patients (13%) in the placebo group, in 10 of 57 patients (18%) in the 28-mg efruxifermin group (difference from ...

As of the end of March, more than 17,000 MASH patients were actively taking Rezdiffra, compared with more than 11,800 at year-end 2024, according to Madrigal. Rezdiffra’s speed of adding new ...

Semaglutide shows promise in MASH treatment, achieving significant MASH resolution and fibrosis improvement in the ESSENCE trial. Tolerability issues and insurance coverage challenges lead to 20% ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated steatohepatitis (MASH). Researchers have developed an innovative ...

Known as a “silent disease”, metabolic dysfunction-associated steatohepatitis (MASH) is affecting a growing number of people, with an expected 27 million cases in the United States by 2030.

The Cincinnati Reds had a four-run lead and their ace on the mound. It was an ideal start to facing the NL Central-leading Chicago Cubs in the first of six head-to-head games through June 1.

The presentation focuses on the use of the MASH Resolution Index (MASHResInd) algorithm to predict MASH resolution on biopsy in patients treated with pemvidutide, Altimmune’s 1:1 GLP-1/glucagon ...

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH ...

More than half of adults with MASH receiving semaglutide had resolution of steatohepatitis at 72 weeks. A reduction in liver fibrosis stage was observed among 36.8% of the semaglutide group.